Li L - Search Results

1

An inhibition of ceruloplasmin expression induced by cerebral ischemia in the cortex and hippocampus of rats.

Li YW, Li L, Zhao JY. Li YW, et al. Among authors: li l. Neurosci Bull. 2008 Feb;24(1):13-20. doi: 10.1007/s12264-008-1017-2. Neurosci Bull. 2008. PMID: 18273071 Free PMC article.

2

D-Ala2-GIP-glu-PAL is neuroprotective in a chronic Parkinson's disease mouse model and increases BNDF expression while reducing neuroinflammation and lipid peroxidation.

Li Y, Liu W, Li L, Hölscher C. Li Y, et al. Among authors: li l. Eur J Pharmacol. 2017 Feb 15;797:162-172. doi: 10.1016/j.ejphar.2016.11.050. Epub 2016 Nov 29. Eur J Pharmacol. 2017. PMID: 27913104 Free article.

3

Neuroprotective effects of a triple GLP-1/GIP/glucagon receptor agonist in the APP/PS1 transgenic mouse model of Alzheimer's disease.

Tai J, Liu W, Li Y, Li L, Hölscher C. Tai J, et al. Among authors: li y, li l. Brain Res. 2018 Jan 1;1678:64-74. doi: 10.1016/j.brainres.2017.10.012. Epub 2017 Oct 16. Brain Res. 2018. PMID: 29050859 Free article.

4

Therapeutic Potential of Genipin in Central Neurodegenerative Diseases.

Li Y, Li L, Hölscher C. Li Y, et al. Among authors: li l. CNS Drugs. 2016 Oct;30(10):889-97. doi: 10.1007/s40263-016-0369-9. CNS Drugs. 2016. PMID: 27395402 Review.

5

Neuroprotective effects of an oxyntomodulin analogue in the MPTP mouse model of Parkinson's disease.

Liu W, Li Y, Jalewa J, Saunders-Wood T, Li L, Hölscher C. Liu W, et al. Among authors: li y, li l. Eur J Pharmacol. 2015 Oct 15;765:284-90. doi: 10.1016/j.ejphar.2015.08.038. Epub 2015 Aug 21. Eur J Pharmacol. 2015. PMID: 26302060

6

Neuroprotective effects of a GIP analogue in the MPTP Parkinson's disease mouse model.

Li Y, Liu W, Li L, Hölscher C. Li Y, et al. Among authors: li l. Neuropharmacology. 2016 Feb;101:255-63. doi: 10.1016/j.neuropharm.2015.10.002. Epub 2015 Nov 10. Neuropharmacology. 2016. PMID: 26453962 Free article.

7

The Novel Dual GLP-1/GIP Receptor Agonist DA-CH5 Is Superior to Single GLP-1 Receptor Agonists in the MPTP Model of Parkinson's Disease.

Zhang L, Zhang L, Li Y, Li L, Melchiorsen JU, Rosenkilde M, Hölscher C. Zhang L, et al. Among authors: li y, li l. J Parkinsons Dis. 2020;10(2):523-542. doi: 10.3233/JPD-191768. J Parkinsons Dis. 2020. PMID: 31958096

8

Incretin-based therapy for type 2 diabetes mellitus is promising for treating neurodegenerative diseases.

Li Y, Li L, Hölscher C. Li Y, et al. Among authors: li l. Rev Neurosci. 2016 Oct 1;27(7):689-711. doi: 10.1515/revneuro-2016-0018. Rev Neurosci. 2016. PMID: 27276528 Review.

9

Geniposide effectively reverses cognitive impairment and inhibits pathological cerebral damage by regulating the mTOR Signal pathway in APP∕PS1 mice.

Zhang Z, Gao W, Wang X, Zhang D, Liu Y, Li L. Zhang Z, et al. Among authors: li l. Neurosci Lett. 2020 Feb 16;720:134749. doi: 10.1016/j.neulet.2020.134749. Epub 2020 Jan 11. Neurosci Lett. 2020. PMID: 31935433

10

Neuroprotective effect of morroniside on focal cerebral ischemia in rats.

Wang W, Xu J, Li L, Wang P, Ji X, Ai H, Zhang L, Li L. Wang W, et al. Among authors: li l. Brain Res Bull. 2010 Oct 30;83(5):196-201. doi: 10.1016/j.brainresbull.2010.07.003. Epub 2010 Jul 14. Brain Res Bull. 2010. PMID: 20637265

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99,448 results

Search Page

Filters